Your browser doesn't support javascript.
loading
Genomic characterisation of hormone receptor-positive breast cancer arising in very young women.
Luen, S J; Viale, G; Nik-Zainal, S; Savas, P; Kammler, R; Dell'Orto, P; Biasi, O; Degasperi, A; Brown, L C; Láng, I; MacGrogan, G; Tondini, C; Bellet, M; Villa, F; Bernardo, A; Ciruelos, E; Karlsson, P; Neven, P; Climent, M; Müller, B; Jochum, W; Bonnefoi, H; Martino, S; Davidson, N E; Geyer, C; Chia, S K; Ingle, J N; Coleman, R; Solbach, C; Thürlimann, B; Colleoni, M; Coates, A S; Goldhirsch, A; Fleming, G F; Francis, P A; Speed, T P; Regan, M M; Loi, S.
Afiliación
  • Luen SJ; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.
  • Viale G; International Breast Cancer Study Group Central Pathology Office, IEO European Institute of Oncology IRCCS, University of Milan, Milan, Italy.
  • Nik-Zainal S; Department of Medical Genetics & MRC Cancer Unit, The Clinical School, University of Cambridge, Cambridge, UK.
  • Savas P; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.
  • Kammler R; International Breast Cancer Study Group, Coordinating Center, Central Pathology Office, Bern, Switzerland.
  • Dell'Orto P; International Breast Cancer Study Group Central Pathology Office, Department of Pathology, IEO European Institute of Oncology IRCCS, Milan, Italy.
  • Biasi O; Division of Pathology and Laboratory Medicine, IEO European Institute of Oncology IRCCS, Milan, Italy.
  • Degasperi A; Department of Medical Genetics & MRC Cancer Unit, The Clinical School, University of Cambridge, Cambridge, UK.
  • Brown LC; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.
  • Láng I; Istenhegyi Health Center Oncology Clinic, National Institute of Oncology, Budapest, Hungary.
  • MacGrogan G; Biopathology Department, Institut Bergonié Comprehensive Cancer Centre, Bordeaux, France.
  • Tondini C; Osp. Papa Giovanni XXIII, Bergamo, Italy.
  • Bellet M; Vall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital, Barcelona, Spain.
  • Villa F; Oncology Unit, Department of Oncology, Alessandro Manzoni Hospital, ASST Lecco, Lecco, Italy.
  • Bernardo A; ICS Maugeri IRCCS, Medical Oncology Unit of Pavia Institute, Italy.
  • Ciruelos E; University Hospital 12 de Octubre, Madrid, Spain.
  • Karlsson P; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Neven P; Gynecologic Oncology and Multidisciplinary Breast Center, University Hospitals UZ-Leuven, KU Leuven, Leuven, Belgium.
  • Climent M; Instituto Valenciano de Oncologia, Valencia, Spain.
  • Müller B; Chilean Cooperative Group for Oncologic Research (GOCCHI), Santiago, Chile.
  • Jochum W; Institute of Pathology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland; Swiss Group for Clinical Cancer Research (SAKK), Berne, Switzerland.
  • Bonnefoi H; Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U1218, Bordeaux, France; European Organization for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
  • Martino S; The Angeles Clinic and Research Institute, Santa Monica, USA.
  • Davidson NE; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, USA.
  • Geyer C; Houston Methodist Cancer Center, NRG Oncology, Houston, USA.
  • Chia SK; BC Cancer and Canadian Cancer Trials Group, Vancouver, Canada.
  • Ingle JN; Mayo Clinic, Rochester, Minnesota, USA.
  • Coleman R; National Institute for Health Research (NIHR) Cancer Research Network, University of Sheffield, Sheffield, UK.
  • Solbach C; Breast Center, University Hospital, Goethe University Frankfurt, Frankfurt, Germany.
  • Thürlimann B; Swiss Group for Clinical Cancer Research (SAKK), Berne, Switzerland; Breast Center, Kantonsspital, St. Gallen, Switzerland.
  • Colleoni M; Division of Medical Senology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Coates AS; International Breast Cancer Study Group and University of Sydney, Sydney, Australia.
  • Goldhirsch A; International Breast Cancer Study Group (IBCSG), Bern Switzerland and IEO European Institute of Oncology IRCCS, Milan, Italy.
  • Fleming GF; Section of Hematology Oncology, The University of Chicago, Chicago, USA.
  • Francis PA; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.
  • Speed TP; Bioinformatics Division, Walter and Eliza Hall Institute, Melbourne, Australia.
  • Regan MM; Division of Biostatistics, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA.
  • Loi S; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia. Electronic address: sherene.loi@petermac.org.
Ann Oncol ; 34(4): 397-409, 2023 04.
Article en En | MEDLINE | ID: mdl-36709040
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Australia